PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-74

  1. 193 Posts.
    lightbulb Created with Sketch. 140
    completely agree tanimrod and your points. I think they are valid concerns and you can't argue them.

    I just think that when (not if ) we get P3 we will have multiple companies in multiple jurisdictions lining up to sign deals. Paul / simon recently talk about USA / China / South America / Middle East. all lies ? let's see.

    BP need a pipeline and this is a pretty good and a pretty cheap bet for BP. they spend billions each year on pipeline.

    for sure we can get delayed by the fda etc and that will be a problem. yes a CR may come. but I see a clear path if most of the stars align to get out of this mess.

    and if we do ? what is a P3 potential blockbuster asset with 2-3 years to Revenue, consistent p1-2 and real world data worth in 6-12 months ? my money is on circa a billion Aussie.

    if we get to that point I would hope we get a better board and ceo/chairman separation and then that noise too will hopefully subside.

    we will be heading north or south soon enough. I think we know where the respective punters in this thread stand.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.